Skip to content
← Full study record

NCT00543543 · BASELINE

Baseline characteristics

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) · Source last updated 2018-11-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      315
    2. group Id
      BG001
      value
      7106
    3. group Id
      BG002
      value
      310
    4. group Id
      BG003
      value
      7109
    5. group Id
      BG004
      value
      14840
    units
    Participants
groups
  1. description
    V503 (9-Valent Human Papillomavirus \[HPV\] Vaccine) low-dose 0.5 mL injection in a 3-dose regimen in the base study.
    id
    BG000
    title
    Low-dose V503
  2. description
    V503 (9-Valent HPV Vaccine) mid-dose 0.5 mL injection in a 3-dose regimen in the base study. A subset of participants (Cohort 1) received a fourth V503 mid-dose vaccination in the extension study.
    id
    BG001
    title
    Mid-dose V503
  3. description
    V503 (9-Valent HPV Vaccine) high-dose 0.5 mL injection in a 3-dose regimen in the base study.
    id
    BG002
    title
    High-dose V503
  4. description
    Gardasil (4-Valent HPV Vaccine) 0.5 mL injection in a 3-dose regimen in the base study. Participants (Cohort 2) were offered the V503 mid-dose 3-dose regimen in the extension study.
    id
    BG003
    title
    Gardasil
  5. description
    Total of all reporting groups
    id
    BG004
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          2.4
          value
          21.7
        2. group Id
          BG001
          spread
          2.5
          value
          21.9
        3. group Id
          BG002
          spread
          2.4
          value
          21.9
        4. group Id
          BG003
          spread
          2.5
          value
          21.8
        5. group Id
          BG004
          spread
          2.5
          value
          21.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          315
        2. group Id
          BG001
          value
          7106
        3. group Id
          BG002
          value
          310
        4. group Id
          BG003
          value
          7109
        5. group Id
          BG004
          value
          14840
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
        5. group Id
          BG004
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      315
    2. group Id
      BG001
      value
      7106
    3. group Id
      BG002
      value
      310
    4. group Id
      BG003
      value
      7109
    5. group Id
      BG004
      value
      14840
    units
    Participants
groups
  1. description
    V503 (9-Valent Human Papillomavirus \[HPV\] Vaccine) low-dose 0.5 mL injection in a 3-dose regimen in the base study.
    id
    BG000
    title
    Low-dose V503
  2. description
    V503 (9-Valent HPV Vaccine) mid-dose 0.5 mL injection in a 3-dose regimen in the base study. A subset of participants (Cohort 1) received a fourth V503 mid-dose vaccination in the extension study.
    id
    BG001
    title
    Mid-dose V503
  3. description
    V503 (9-Valent HPV Vaccine) high-dose 0.5 mL injection in a 3-dose regimen in the base study.
    id
    BG002
    title
    High-dose V503
  4. description
    Gardasil (4-Valent HPV Vaccine) 0.5 mL injection in a 3-dose regimen in the base study. Participants (Cohort 2) were offered the V503 mid-dose 3-dose regimen in the extension study.
    id
    BG003
    title
    Gardasil
  5. description
    Total of all reporting groups
    id
    BG004
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          2.4
          value
          21.7
        2. group Id
          BG001
          spread
          2.5
          value
          21.9
        3. group Id
          BG002
          spread
          2.4
          value
          21.9
        4. group Id
          BG003
          spread
          2.5
          value
          21.8
        5. group Id
          BG004
          spread
          2.5
          value
          21.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          315
        2. group Id
          BG001
          value
          7106
        3. group Id
          BG002
          value
          310
        4. group Id
          BG003
          value
          7109
        5. group Id
          BG004
          value
          14840
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
        5. group Id
          BG004
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice